Latest filing published 03 Apr 2023 for Supriya Lifescience Limited, €28k.
Filing timeline
BuySaleSatish Waman Wagh: trading record in brief
This profile gathers the share dealings of Satish Waman Wagh in Supriya Lifescience Limited. Between 28 February 2023 and 31 March 2023, the trades on record add up to 6 filings.
Purchases make up the whole of the open-market record (6 purchases, €101k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
In size, the median ticket on the buying side is €18k. None of the 6 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The record was last updated on 3 April 2023 with an open-market purchase (€28k) in Supriya Lifescience Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Satish Waman Wagh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,000 shares@ ₹190.220327.2% of flowEquity SharesSEBI:ad6317c156a07b97977355e156da8988abccf0b2Canonical exit: 29 Jun 2023 (T+90)
- 14,000 shares@ ₹177.785627.5% of flowEquity SharesSEBI:0f45231f935e903d70d879d68ef9fd39893704fcCanonical exit: 27 Jun 2023 (T+90)
- 2,000 shares@ ₹203.69054.6% of flowEquity SharesSEBI:7d0a1a2b3b4c7ab910c9d13ab8c99ad2846d5604Canonical exit: 1 Jun 2023 (T+90)
- 8,000 shares@ ₹203.690818.4% of flowEquity SharesSEBI:942bd4b3d6b712c46ddee264e56a5ae9ebc64647Canonical exit: 1 Jun 2023 (T+90)
- 8,000 shares@ ₹198.057517.8% of flowEquity SharesSEBI:61ccd40f30820cdc8d03ad416bdd010469cadc04Canonical exit: 29 May 2023 (T+90)
- 2,000 shares@ ₹198.05754.5% of flowEquity SharesSEBI:ad17473ab9ff1ff8f679c082c9515d9b9e35d6b5Canonical exit: 29 May 2023 (T+90)
6 of 6 declarations